title: Surfactant protein-A suppresses eosinophil-mediated killing of Mycoplasma pneumoniae in allergic lungs.
abstract: Surfactant protein-A (SP-A) has well-established functions in reducing bacterial and viral infections but its role in chronic lung diseases such as asthma is unclear. Mycoplasma pneumoniae (Mp) frequently colonizes the airways of chronic asthmatics and is thought to contribute to exacerbations of asthma. Our lab has previously reported that during Mp infection of non-allergic airways, SP-A aides in maintaining airway homeostasis by inhibiting an overzealous TNF-alpha mediated response and, in allergic mice, SP-A regulates eosinophilic infiltration and inflammation of the airway. In the current study, we used an in vivo model with wild type (WT) and SP-A(-/-) allergic mice challenged with the model antigen ovalbumin (Ova) that were concurrently infected with Mp (Ova+Mp) to test the hypothesis that SP-A ameliorates Mp-induced stimulation of eosinophils. Thus, SP-A could protect allergic airways from injury due to release of eosinophil inflammatory products. SP-A deficient mice exhibit significant increases in inflammatory cells, mucus production and lung damage during concurrent allergic airway disease and infection (Ova+Mp) as compared to the WT mice of the same treatment group. In contrast, SP-A deficient mice have significantly decreased Mp burden compared to WT mice. The eosinophil specific factor, eosinophil peroxidase (EPO), which has been implicated in pathogen killing and also in epithelial dysfunction due to oxidative damage of resident lung proteins, is enhanced in samples from allergic/infected SP-A(-/-) mice as compared to WT mice. In vitro experiments using purified eosinophils and human SP-A suggest that SP-A limits the release of EPO from Mp-stimulated eosinophils thereby reducing their killing capacity. These findings are the first to demonstrate that although SP-A interferes with eosinophil-mediated biologic clearance of Mp by mediating the interaction of Mp with eosinophils, SP-A simultaneously benefits the airway by limiting inflammation and damage.
authors.affiliation: Department of Cell Biology, Duke University Medical Center, Durham, North Carolina, United States of America. j.ledford@cellbio.duke.edu
authors.forename: Julie G
authors.initials: JG
authors.lastname: Ledford
authors.forename: Sambuddho
authors.initials: S
authors.lastname: Mukherjee
authors.forename: Michele M
authors.initials: MM
authors.lastname: Kislan
authors.forename: Julia L
authors.initials: JL
authors.lastname: Nugent
authors.forename: John W
authors.initials: JW
authors.lastname: Hollingsworth
authors.forename: Jo Rae
authors.initials: JR
authors.lastname: Wright
mesh_terms: D000418:Albumins / Q000378:metabolism; D000818:Animals; D002118:Calcium / Q000378:metabolism; D004804:Eosinophils / Q000276:immunology / Q000378:metabolism*; D005434:Flow Cytometry; D005786:Gene Expression Regulation; D006801:Humans; D006967:Hypersensitivity / Q000276:immunology* / Q000378:metabolism; D007249:Inflammation; D008168:Lung / Q000276:immunology* / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D008954:Models, Biological; D009177:Mycoplasma pneumoniae / Q000378:metabolism*; D011019:Pneumonia, Mycoplasma / Q000378:metabolism* / Q000382:microbiology*; D037662:Pulmonary Surfactant-Associated Protein A / Q000378:metabolism*
chemical_list: D000418:Albumins; D037662:Pulmonary Surfactant-Associated Protein A; D002118:Calcium